Literature DB >> 16391016

Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels.

Lorena Zentilin1, Sabrina Tafuro, Serena Zacchigna, Nikola Arsic, Lucia Pattarini, Milena Sinigaglia, Mauro Giacca.   

Abstract

Vascular endothelial growth factor (VEGF) is a key regulator of blood vessel formation during both vasculogenesis and angiogenesis. The prolonged expression of VEGF in the normoperfused skeletal muscles of adult rodents after gene transfer using AAV vectors induces the formation of a large set of new capillaries and small arteries. Notably, this process is accompanied by the massive infiltration by mononuclear cells. This observation raises the possibility that these cells might represent circulating progenitors that are eventually incorporated in the newly formed vessels. Here we explore this possibility by exploiting 4 different experimental models based on (a) the transplantation of male bone marrow into female recipients; (b) the transplantation of Tie2-GFP transgenic bone marrow; (c) the transplantation of bone marrow in the presence of erythropoietin (EPO), a mobilizer of endothelial progenitor cells (EPCs); and (d) the reimplantation of ex vivo-expanded EPCs. In all 4 models, VEGF acted as a powerful attractor of bone marrow-derived mononuclear cells, bearing different myeloid and endothelial markers proper of the EPCs to the sites of neovascularization. In no case, however, were the attracted cells incorporated in the newly formed vasculature. These observations indicate that new blood vessel formation induced by VEGF occurs through bona fide sprouting angiogenesis; the contribution of the infiltrating bone marrow-derived cells to this process still remains enigmatic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391016     DOI: 10.1182/blood-2005-08-3215

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

Review 1.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

2.  Angiomyeloproliferative lesions following autologous stem cell therapy.

Authors:  Duangpen Thirabanjasak; Kavirach Tantiwongse; Paul Scott Thorner
Journal:  J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 10.121

3.  Regulation of endothelial progenitor cell release by Wnt signaling in bone marrow.

Authors:  Xiaochen Liu; Jeffrey McBride; Yueping Zhou; Zuguo Liu; Jian-Xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-11       Impact factor: 4.799

4.  Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages.

Authors:  Qi Hao; Jianrong Liu; Rajita Pappu; Hua Su; Radoslaw Rola; Rodney A Gabriel; Chanhung Z Lee; William L Young; Guo-Yuan Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-18       Impact factor: 8.311

5.  Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger.

Authors:  Gerard J Madlambayan; Jason M Butler; Koji Hosaka; Marda Jorgensen; Dongtao Fu; Steven M Guthrie; Anitha K Shenoy; Adam Brank; Kathryn J Russell; Jaclyn Otero; Dietmar W Siemann; Edward W Scott; Christopher R Cogle
Journal:  Blood       Date:  2009-08-28       Impact factor: 22.113

Review 6.  Assessing identity, phenotype, and fate of endothelial progenitor cells.

Authors:  Karen K Hirschi; David A Ingram; Mervin C Yoder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

7.  Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats.

Authors:  Junming Tang; Jianing Wang; Fei Zheng; Xia Kong; Linyun Guo; Jianye Yang; Lei Zhang; Yongzhang Huang
Journal:  Mol Cell Biochem       Date:  2010-01-08       Impact factor: 3.396

8.  Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage.

Authors:  Matteo Centola; Franca Abbruzzese; Celeste Scotti; Andrea Barbero; Gianluca Vadalà; Vincenzo Denaro; Ivan Martin; Marcella Trombetta; Alberto Rainer; Anna Marsano
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

9.  Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea.

Authors:  Sanja Jelic; David J Lederer; Tessa Adams; Margherita Padeletti; Paolo C Colombo; Phillip Factor; Thierry H Le Jemtel
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

10.  Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction.

Authors:  Tashera E Perry; Minjung Song; Daryl J Despres; Soo Mi Kim; Hong San; Zu-Xi Yu; Nalini Raghavachari; Jurgen Schnermann; Richard O Cannon; Donald Orlic
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.